For Patients
Learn more about MCGI
The Maine Cancer Genomics Initiative (MCGI) is an alliance of Maine oncology providers, led by The Jackson Laboratory (JAX), aimed at making precision medicine, innovative clinical trials, access to targeted therapies and novel technology available for cancer patients throughout Maine.
MCGI brings innovative cancer genomic testing, education and drug access infrastructure to Maine, with nearly every oncology practice in the state as a partner. Initially driven by the need for greater availability of cancer genomic testing for Maine's cancer patients, MCGI has become a model for community precision oncology, or personalized cancer care, in a rural setting.
Just announced! On October 8, 2020, The Jackson Laboratory announced the next phase of MCGI. Since its establishment in 2016, MCGI has been focused on providing patients with access to genomic testing and facilitating interpretability of test results through educational activities for clinicians. Over the next five years, thanks to an $11.8 million grant from the Harold Alfond Foundation, MCGI will now advance how clinicians and patients can act upon their individual results, by providing greater access to novel targeted therapies. Learn more in the announcement here.
Are you a cancer patient in Maine? Are you an oncologist in need of genomic testing services or clinical education? Learn more about how MCGI can help you!
MCGI is focused on facilitating state-wide access to cancer genomic testing, working with clinicians to effectively interpret test results, and making access to treatments and clinical trials possible.
Betty Walls is fighting cancer with an upbeat attitude and advanced genomic treatment through MCGI with Dr. Philip Brooks at Mount Desert Island Hospital.
MCGI, led by The Jackson Laboratory, is located at the Harold Alfond Center for Cancer Care in August, Maine. Nearly every oncologist in Maine is enrolled in MCGI.
At Jefferson Cary Cancer Center, Dr. Allan Espinosa brings MCGI options to Aroostook County, Maine.
From cancer genomic testing to clinical trials, John Pierce is exploring the latest advances to address his medical issues.
